ACH 702

Known as: ACH-702, ACH702 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2018
012320102018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The virulence of tuberculosis infections resistant to conventional combination drug regimens cries for the design of potent… (More)
Is this relevant?
2013
2013
Due to the emergency of multidrug-resistant strains of Mycobacterium tuberculosis, is necessary the evaluation of new compounds… (More)
  • figure 1
Is this relevant?
2012
2012
Many bacterial infections involve slow or nondividing bacterial growth states and localized high cell densities. Antibiotics with… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
ACH-702, a novel isothiazoloquinolone (ITQ), was assessed for antibacterial activity against a panel of Gram-positive and Gram… (More)
Is this relevant?
2010
2010
ACH-702 is a new isothiazoloquinolone with potent in vitro and in vivo activities against important bacterial pathogens… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2010
2010
In this work, we describe the activity of ACH-702 against clinical isolates of Mycobacterium tuberculosis and six different… (More)
Is this relevant?